/ Pipeline
Beyond ALS: A Platform
for Neuroimmune Disorders
Post-ALS expansion will target:
- MS (Multiple Sclerosis)
- Parkinson’s Disease
- Alzheimer’s Disease
All conditions share common inflammatory pathways that SELanetx™ can regulate via immune reprogramming.